tiprankstipranks
Trending News
More News >
Mayne Pharma Group (AU:MYX)
ASX:MYX
Advertisement

Mayne Pharma Group (MYX) Revenue

Compare
43 Followers

Mayne Pharma Group Revenue

Mayne Pharma Group had a revenue of 213.05M in the quarter ending Dec 31, 2024, with 6.28%. This bring the company's revenue in the last twelve months to 413.53M, Decreased 6.47%. In the fiscal year ending Dec 31, 2024, Mayne Pharma Group had annual revenue of 388.15M with 111.43% growth.
Revenue (ttm)
413.53M
Revenue Growth
5.07%
P/S Ratio
1.08
Revenue/Employee
$456,648
Employees
850
Market Cap
$420.04M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
388.15M204.56M+111.43%
Dec 31, 2023
183.59M26.44M+16.82%
Dec 31, 2022
157.15M-243.63M-60.79%
Dec 31, 2021
400.78M-56.20M-12.30%
Dec 31, 2020
456.99M-68.22M-12.99%
Dec 31, 2019
525.21M-5.11M-0.96%
Dec 31, 2018
530.31M-42.28M-7.38%
Dec 31, 2017
572.60M305.32M+114.23%
Dec 31, 2016
267.28M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis